Tetrandrine, a compound common in Chinese traditional medicine, preferentially kills breast cancer tumor initiating cells (TICs) in vitro

Cancers

Volumn 3, Issue 2, 2011, Pages 2274-2285

  Xu, Wei ^a   Debeb, Bisrat G ^a   Lacerda, Lara ^a   Li, Jessica ^a   Woodward, Wendy A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Cancer stem cells; Tetrandrine; Tumor initiating cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; TETRANDRINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STEM CELL; CELL AGGREGATION; CELL ASSAY; CELL STRAIN SUM 149; CELL STRAIN SUM 159; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME INHIBITION; EX VIVO STUDY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFLAMMATORY BREAST CANCER; MAMMOSPHERE FORMATION; MITOSIS INHIBITION;

EID: 79959701824     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3022274     Document Type: Article

References (39)

1. Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983-3988.
2. Ginestier, C.; Hur, M.H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C.G.; Liu, S.; et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1, 555-567.
3. Dontu, G.; Abdallah, W.M.; Foley, J.M.; Jackson, K.W.; Clarke, M.F.; Kawamura, M.J.; Wicha, M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Gene. Develop. 2003, 17, 253-270.
4. Fillmore, C.M.; Kuperwasser, C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008, 10, R25.
5. Mani, S.A.; Guo, W.; Liao, M.J.; Eaton, E.N.; Ayyanan, A.; Zhou, A.Y.; Brooks, M.; Reinhard, F.; Zhang, C.C.; Shipitsin, M.; et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133, 704-715.
6. Phillips, T.M.; McBride, W.H.; Pajonk, F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 2006, 98, 1777-1785.
7. Ho, L.J.; Chang, D.M.; Chang, M.L.; Kuo, S.Y.; Lai, J.H. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J. Rheumatol. 1999, 26, 14-24.
8. Kwan, C.Y.; Achike, F.I. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: Cardiovascular effects and mechanisms of action. Acta Pharmacol. Sin. 2002, 23, 1057-1068.
9. Wang, G.; Lemos, J.R.; Iadecola, C. Herbal alkaloid tetrandrine: From an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol. Sci. 2004, 25, 120-123.
10. Felix, J.P.; King, V.F.; Shevell, J.L.; Garcia, M.L.; Kaczorowski, G.J.; Bick, I.R.C.; Slaughter, R.S.; et al. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: Evidence for interaction at the diltiazem-binding site. Biochemistry 1992, 31, 11793-11800.
11. Liu, Z.L.; Hirano, T.; Tanaka, S.; Onda, K.; Oka, K. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. J. Pharm. Pharmacol. 2003, 55, 1531-1537.
12. He, B.C.; Gao, J.L.; Zhang, B.Q.; Luo, Q.; Shi, Q.; Kim, S.H.; Huang, E.; Gao, Y.; Yang, K.; Wagner, E.R.; et al. Tetrandrine inhibits Wnt/{beta}-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol. Pharmacol. 2011, 79, 211-219.
13. Zhang, M.; Atkinson, R.L.; Rosen, J.M. Selective targeting of radiation-resistant tumor-initiating cells. Proc. Natl. Acad. Sci. USA 2010, 107, 3522-3527.
14. Korkaya, H.; Paulson, A.; Charafe-Jauffret, E.; Ginestier, C.; Brown, M.; Dutcher, J.; Clouthier, S.G.; Wicha, M.S. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol. 2009, 7, e1000121.
15. Atkinson, R.L.; Zhang, M.; Diagaradjane, P.; Peddibhotla, S.; Contreras, A.; Hilsenbeck, S.G. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci. Transl. Med. 2010, 2, 55-79.
16. Charafe-Jauffret, E.; Ginestier, C.; Iovino, F.; Tarpin, C.; Diebel, M.; Esterni, B.; Houvenaeghel, G.; Extra, J.-M.; Bertucci, F.; Jacquemier, J.; et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin. Cancer Res. 2010, 16, 45-55.
17. Bao, S.; Wu, Q.; McLendon, R.E.; Hao, Y.; Shi, Q.; Hjelmeland, A.B.; Dewhirst, M.W.; Bigner, D.D.; Rich, J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444, 756-760.
18. Woodward, W.A.; Chen, M.S.; Behbod, F.; Alfaro, M.P.; Buchholz, T.A.; Rosen, J.M. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. USA 2007, 104, 618-623.
19. Debeb, B.G.; Xu, W.; Mok, H.; Li, L.; Robertson, F.; Ueno, N.T.; Reuben, J.; Lucci, A.; Cristofanilli, M.; Woodward, W.A. Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions. Int. J. Radiat. Oncol. Biol. Phys. 2009, 76, 889-895.
20. Woodward, W.A.; Bristow, R.G. Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Semin. Radiat. Oncol. 2009, 19, 87-95.
21. Creighton, C.J.; Li, X.; Landis, M.; Dixon, J.M.; Neumeister, V.M.; Sjolund, A.; Rimm, D.L.; Wong, H.; Rodriguez, A.; Herschkowitz, J.I.; et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA 2009, 106, 13820-13825.
22. Li, X.; Lewis, M.T.; Huang, J.; Gutierrez, C.; Osborne, C.K.; Wu, M.F.; Hilsenbeck, S.G.; Pavlick, A.; Zhang, X.; Chamness, G.C.; et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 2008, 100, 672-679.
23. Tanei, T.; Morimoto, K.; Shimazu, K.; Kim, S.J.; Tanji, Y.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 2009, 15, 4234-4241.
24. Gupta, P.B.; Onder, T.T.; Jiang, G.; Tao, K.; Kuperwasser, C.; Weinberg, R.A.; Lander, E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138, 645-659.
25. Li, Y.; Zhang, T.; Korkaya, H.; Liu, S.; Lee, H.F.; Newman, B.; Yu, Y.; Clouthier, S.G.; Schwartz, S.J.; Wicha, M.S.; et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin. Cancer Res. 2010, 16, 2580-2590.
26. Lai, Y.L.; Chen, Y.J.; Wu, T.Y.; Wang, S.Y.; Chang, K.H.; Chung, C.H.; Chen, M.L. Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anti-Cancer Drugs 1998, 9, 77-81.
27. Meng, L.H.; Zhang, H.; Hayward, L.; Takemura, H.; Shao, R.G.; Pommier, Y. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res. 2004, 64, 9086-9092.
28. Ng, L.T.; Chiang, L.C.; Lin, Y.T.; Lin, C.C. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am. J. Chin. Med. 2006, 34, 125-135.
29. Liu, C.; Gong, K.; Mao, X.; Li, W. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int. J. Cancer 2011, doi: 10.1002/ijc.25817.
30. Chen Y, Chen JC, Tseng SH. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int. J. Cancer 2009, 124, 2260-2269.
31. Chen, Y.; Tseng, S.H. The Potential of tetrandrine against gliomas. Anti-Cancer Agent. Med. Chem. 2010, 10, 534-542.
32. Chen, Y.; Chen, J.C.; Tseng, S.H. Effects of tetrandrine plus radiation on neuroblastoma cells. Anticancer Res. 2009, 29, 3163-3171.
33. Chang, K.H.; Chen, M.L.; Chen, H.C.; Huang, Y.W.; Wu, T.Y.; Chen, Y.J. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma 1999, 46, 196-200.
34. Sun, A.X.; Ye, Z.G.; Li, C.Y.; Xue, B.Y.; Li, L.F.; Cao, X.F.; Yang, Q.; Dai, B.Q. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro. Zhongguo Yao Li Xue Bao 1999, 20, 69-73.
35. Bunting, K.D.; Zhou, S.; Lu, T.; Sorrentino, B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000, 96, 902-909.
36. Riccioni, R.; Dupuis, M.L.; Bernabei, M.; Petrucci, E.; Pasquini, L.; Mariani, G.; Cianfriglia, M.; Testa, U. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol. Dis. 2010, 45, 86-92.
37. Fuerer, C.; Nusse, R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PloS One 2010, 5, e9370.
38. Xu, W.L.; Shen, H.L.; Ao, Z.F.; Chen, B.A.; Xia, W.; Gao, F.; Zhang, Y.N. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leukemia Res. 2006, 30, 407-413.
39. Gralla, E.J.; Coleman, G.L.; Jonas, A.M. Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys. Cancer Chemother. Rep. 1974, 5, 79-85.